BLIMP1 negatively regulates IL-2 signaling in T cells
Science Advances · 18.07.2025 · 11 (29)
DOI: 10.1126/sciadv.adx8105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 18.07.2025. Verfasst von Suyasha Roy und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 2…. Hauptthemen laut MEDLINE: Interleukin-2, Positive Regulatory Domain I-Binding Factor 1, Signal Transduction, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Interleukin-2 (IL-2) regulates immune homeostasis by fine-tuning the balance between effector and regulatory T (T reg ) cells. To identify regulators of IL-2 signaling, we performed genome-wide CRISPR-knockout screening in IL-2–dependent cells derived from a patient with adult T cell leukemia (ATL) and found enrichment of single guide RNAs targeting PRDM1 , which encodes B lymphocyte–induced maturation protein 1 (BLIMP1). BLIMP1 inhibits IL-2 production by T cells; however, its role in IL-2 signaling remains unknown. Here, we show that overexpressing Prdm1 down-regulated IL-2 signaling, whereas Prdm1 -deficiency enhanced IL-2 signaling in mouse CD4 + T cells and T reg cells with augmented IL-2 signaling in T cells from influenza-infected mice and during adoptive T cell transfer–induced colitis. Deleting PRDM1 in human CD4 + T cells and T reg cells also increased IL-2 signaling. Furthermore, CD4 + T cells from patients with ATL expressed less BLIMP1 and had enhanced IL-2 signaling, whereas overexpressing PRDM1 in ATL cells suppressed IL-2 signaling. Thus, BLIMP1 inhibits IL-2 signaling during normal and pathophysiological responses, suggesting that manipulating BLIMP1 could have therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Laboratory of Epigenome Biology, Systems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Integrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Cutaneous Leukocyte Biology Section, Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Mucosal Immunobiology Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Suyasha Roy, Min Ren, Yaqiang Cao, Keiko Sakamoto, Keisuke Nagao, Rosanne Spolski, Sigrid P Dubois, Brian L Kelsall, James D Phelan, Warren J Leonard
Zitieren
APA
Roy, S., Ren, M., Li, P., Cui, K., Cao, Y., Fisk, B., Markowitz, T. E., Redekar, N., Sakamoto, K., Nagao, K., Oh, J., Spolski, R., Liao, W., Dubois, S. P., Kelsall, B. L., Zhao, K., Phelan, J. D., & Leonard, W. J. (2025). BLIMP1 negatively regulates IL-2 signaling in T cells. Science Advances, 11(29). https://doi.org/10.1126/sciadv.adx8105
Vancouver
Roy S, Ren M, Li P, Cui K, Cao Y, Fisk B, et al. BLIMP1 negatively regulates IL-2 signaling in T cells. Science Advances. 2025;11(29). doi:10.1126/sciadv.adx8105
BibTeX
@article{Roy2025,
author = {Roy, Suyasha and Ren, Min and Li, Peng and Cui, Kairong and Cao, Yaqiang and Fisk, Bryan and Markowitz, Tovah E and Redekar, Neelam and Sakamoto, Keiko and Nagao, Keisuke and Oh, Jangsuk and Spolski, Rosanne and Liao, Wei and Dubois, Sigrid P and Kelsall, Brian L and Zhao, Keji and Phelan, James D and Leonard, Warren J},
title = {BLIMP1 negatively regulates IL-2 signaling in T cells},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {29},
doi = {10.1126/sciadv.adx8105}
}
EUVIMED